FIELD: medicine. SUBSTANCE: invention proposes to use dalargin as an agent showing cholelitholytic effect. An agent increases bile acids concentrations as the bile component and decreases the ability of bile to lithogenesis. EFFECT: enhanced effectiveness of an agent. 8 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR BIOCHEMICAL EVALUATION OF METABOLIC DISORDERS IN BILE ACCOMPANYING LITHOGENESIS | 2015 |
|
RU2593340C1 |
METHOD OF TREATING PATIENTS SUFFERING FROM FIRST STAGE CHOLELITHIASIS | 2012 |
|
RU2519198C2 |
METHOD OF TREATMENT OF PATIENTS SUFFERED WITH CHRONIC OPISTHORCHIASIS | 1997 |
|
RU2135148C1 |
DRUG AND METHOD OF CORRECTION OF BILIARY AND SMALL INTESTINE DYSKINESIA | 2000 |
|
RU2163484C1 |
AGENT SHOWING HOLAGOGUE EFFECT | 1998 |
|
RU2126687C1 |
METHOD FOR TREATING PATIENTS FOR EROSIVE STOMACH AND DUODENUM ULCER DISEASES | 2002 |
|
RU2223740C1 |
METHOD OF TREATING ULCERATIVE COLITIS | 2023 |
|
RU2807131C1 |
AGENT BASED ON L-RHAMNOPYRANOSYL-6-O-METHYL-D-GALACTURONANE, HAVING HYPOLIPIDEMIC ACTIVITY | 2019 |
|
RU2699802C1 |
METHOD FOR OBTAINING LIPOSOMES BEING OF IMMUNOCORRECTING AND HEPATOPROTECTOR ACTION | 2006 |
|
RU2308940C1 |
METHOD FOR TREATING CHOLELITHIASIS PATIENTS FOR HYPERCHOLESTEROLEMIA STATES BY ADMINISTERING HEPATOSAN PREPARATION ACCELERATING CHOLESTEROL OXIDATION IN LIVER | 2006 |
|
RU2306943C1 |
Authors
Dates
1999-12-20—Published
1996-07-23—Filed